22nd Century Group to Announce First Quarter 2020 Financial Results on May 7, 2020
April 28, 2020 06:50 ET
|
22nd Century Group, Inc.
Williamsville, NY, April 28, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced...
FDA Announces Deadline to Submit Comments on 22nd Century Group’s MRTP Application
April 17, 2020 12:15 ET
|
22nd Century Group, Inc.
WILLIAMSVILLE, NY, April 17, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced...
22nd Century Group to Hold Virtual Annual Meeting of Stockholders
April 08, 2020 16:15 ET
|
22nd Century Group, Inc.
Williamsville, NY, April 08, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced...
22nd Century Announces Important New Achievements with KeyGene
March 11, 2020 16:15 ET
|
22nd Century Group, Inc.
Delivers Complete High-Quality Hemp/Cannabis Genome Sequence; Establishes New Proprietary Hemp/Cannabis Bioinformatics Platform WILLIAMSVILLE, N.Y. , March 11, 2020 (GLOBE NEWSWIRE) -- 22nd Century...
22nd Century Group Adds to Leadership Team
March 10, 2020 16:15 ET
|
22nd Century Group, Inc.
WILLIAMSVILLE, N.Y., March 10, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis...
CORRECTION: Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use of Very Low Nicotine Content Cigarettes Does Not Lead to Compensatory Smoking
March 04, 2020 13:03 ET
|
22nd Century Group, Inc.
Williamsville, NY, March 04, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE AMERICAN: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis...
Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use
March 04, 2020 06:50 ET
|
22nd Century Group, Inc.
Williamsville, NY, March 04, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE AMERICAN: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis...
22nd Century Group Appoints New Director and New Chairman
January 13, 2020 06:45 ET
|
22nd Century Group, Inc.
Williamsville, NY, Jan. 13, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine...
22nd Century Group to Present its Modified Risk Tobacco Product Application to FDA’s Tobacco Products Scientific Advisory Committee
December 23, 2019 15:39 ET
|
22nd Century Group, Inc.
Williamsville, NY, Dec. 23, 2019 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine...
FDA Authorizes Marketing of 22nd Century Group’s Proprietary Moonlight® and Moonlight® Menthol Cigarettes
December 17, 2019 13:34 ET
|
22nd Century Group, Inc.
Williamsville, NY, Dec. 17, 2019 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine...